Connect your AI

Zimmer Biomet Holdings ZBH Stock-Based Comp

Stock-Based Comp at other companies

Johnson & JohnsonJNJ

$458M+11.7%

StrykerSYK

$87M+3.6%

PDE

Pro-Dex, Inc.PDEX

$186K+17.7%

CONMEDCNMD

$5.23M+6.7%

VericelVCEL

$9.08M-10.4%

Anika TherapeuticsANIK

$1.83M-28.1%

Other financials

Income statement

Revenue$2.1B+9.3%

Gross profit$1.5B+11.1%

Operating income$373.2M+27.7%

Net income$238.1M+30.8%

EPS (diluted)$1.22+34.1%

Balance sheet

Cash & equivalents$424.2M-69.4%

Total debt$7.5B+4.1%

Total equity$12.7B+2.2%

Total assets$22.7B+2.4%

Cash flow

Operating cash flow$359.4M-6.1%

CapEx$36.3M-18.6%

Free cash flow$323.1M-4.5%

Valuation

Market cap$18.52B-1.4%

Enterprise value$25.57B-0.9%

P/E24.3×+1.5×

P/S2.2×-0.2×

Profitability

Gross margin70%-1.0pp

Operating margin14%-3.0pp

Net margin9.1%-2.8pp

FCF margin17.3%-1.6pp

Returns & leverage

Return on equity6.1%-1.2pp

Debt / equity0.6×0.0×

Current ratio1.7×-0.7×

Where this comes from

Reported directly by Zimmer Biomet Holdings in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Zimmer Biomet Holdings’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zimmer Biomet Holdings's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Zimmer Biomet Holdings's stock-based comp?: Zimmer Biomet Holdings (ZBH) reported stock-based comp of $24.2M in Q1 2026.
How has Zimmer Biomet Holdings's stock-based comp changed year-over-year?: Zimmer Biomet Holdings's stock-based comp increased by 23.5% year-over-year, from $19.6M to $24.2M.
What is the long-term trend for Zimmer Biomet Holdings's stock-based comp?: Over 4 years (2021 to 2025), Zimmer Biomet Holdings's stock-based comp has grown at a 4.4% compound annual growth rate (CAGR), from $76M to $90.2M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.